| All participants | | Interaction with cancer |
---|
Covariates | HR | 95% CI | P value | | HR | 95% CI | P value |
---|
Cancer | | | | | | | |
No | 1.00 (Ref) | | | | — | — | — |
Yes | 2.35 | 2.14 ∼ 2.58 | < 0.001 | |
HF | | | | | | | |
No | 1.00 (Ref) | | | | — | — | 0.891 |
Yes | 1.52 | 1.34 ∼ 1.71 | < 0.001 | |
Diabetes | | | | | | | |
No | 1.00 (Ref) | | | | — | — | 0.560 |
Yes | 0.99 | 0.83 ∼ 1.17 | 0.931 | |
CHD | | | | | | | |
No | 1.00 (Ref) | | | | 0.68 | 0.53 ∼ 0.87 | 0.002 |
Yes | 0.94 | 0.83 ∼ 1.08 | 0.394 | |
HBP | | | | | | | |
No | 1.00 (Ref) | | | | 0.75 | 0.62 ∼ 0.91 | 0.003 |
Yes | 1.07 | 0.93 ∼ 1.22 | 0.322 | |
- * Data was shown as HR (95% CI). Ref, reference; HR: hazard ratio; CI, confidence interval; DM: diabetes; HF: heart failure; CHD: coronary heart disease; HBP: hypertension
- Survey sample weights were taken into consideration in the Cox models accompanying the NHANES data. It examines the association of HF, DM, CHD and HBP with cancer mortality and the interaction with cancer status, adjusting for gender, age, BMI, race, education, marital status, income level and pre-exist comorbidities including cancer, CHD, HF, HBP, DM